Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trial

Saved in:
Bibliographic Details
Other Authors: Greenhalf, William (Other) , Büchler, Markus W. (Other)
Format: Article (Journal)
Language:English
Published: 2014
In: Journal of the National Cancer Institute
Year: 2014, Volume: 106, Issue: 1
ISSN:1460-2105
DOI:10.1093/jnci/djt347
Online Access:Resolving-System, kostenfrei, Volltext: https://academic.oup.com/jnci/article/106/1/djt347/2517966?login=true
Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1093/jnci/djt347
Get full text
Author Notes:Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P.; Palmer, Daniel H.; Cox, Trevor F.; Lamb, Richard F.; Garner, Elizabeth; Campbell, Fiona; Mackey, John R.; Costello, Eithne; Moore, Malcolm J.; Valle, Juan W.; McDonald, Alexander C.; Carter, Ross; Tebbutt, Niall C.; Goldstein, David; Shannon, Jennifer; Dervenis, Christos; Glimelius, Bengt; Deakin, Mark; Charnley, Richard M.; Lacaine, Francois; Scarfe, Andrew G.; Middleton, Mark R.; Anthoney, Alan; Halloran, Christopher M.; Mayerle, Julia; Olah, Attila; Jackson, Richard; Rawcliffe, Charlotte L.; Scarpa, Aldo; Bassi, Claudio; Buechler, Markus W.
Description
Item Description:Gesehen am13.10.2014
Physical Description:Online Resource
ISSN:1460-2105
DOI:10.1093/jnci/djt347